Printer Friendly
The Free Library
14,380,416 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Strategic agreement.


Strategic Agreement: Dialysis dialysis (dīăl`ĭsĭs), in chemistry, transfer of solute (dissolved solids) across a semipermeable membrane. Strictly speaking, dialysis refers only to the transfer of the solute; transfer of the solvent is called osmosis.  care group Fresenius Medical Care Fresenius Medical Care is a German company specializing in the production of medical supplies, primarily to facilitate or aid renal dialysis. It is 37%-owned by the health care company Fresenius SE.  has entered into a five-year sourcing and supply agreement with Amgen Inc. that one analyst says could shore up sales of the Thousand Oaks-based biotech bi·o·tech  
n. Informal
Biotechnology.


biotech
Noun

short for biotechnology

Noun 1.
 giant's aging anemia anemia (ənē`mēə), condition in which the concentration of hemoglobin in the circulating blood is below normal. Such a condition is caused by a deficient number of erythrocytes (red blood cells), an abnormally low level of hemoglobin  drug Epogen and second-generation Aranesp. Amgen will be the sole supplier of red-blood cell boosting drugs for the U.S. operations of Fresenius Medical, a division of Frankfurt, Germany-based Fresenius AG. Analysts say Amgen likely offered discounts and incentives to Fresenius in order to freeze out a competing anemia drug, Cera.
COPYRIGHT 2006 CBJ, L.P.
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2006, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Title Annotation:News of the Week; Fresenius Medical Care supply agreement with Amgen Inc
Publication:Los Angeles Business Journal
Article Type:Brief article
Date:Oct 23, 2006
Words:87
Previous Article:Hollywood low-rise.(News of the Week)(Brief article)
Next Article:Mattel Inc.(Earnings Roundup)
Topics:



Related Articles
BIG WIN FOR AMGEN; LEGAL VICTORY IN ANTI-ANEMIA DRUG BATTLE MAY BOOST STOCK PRICE, ANALYSTS SAY.(BUSINESS)
AMGEN DRUG EFFECTIVE IN FEWER DOSES ARANESP GETS EDGE ON RIVALS.(Business)
Stock buyback, patent victory give bounce to Amgen shares.(Corporate Focus)
Caprius, Inc. Enters into Distribution Agreement with Fresenius Medical Care for the Dialysis Market.
Fresenius Medical Care to Acquire Renal Care Group, Inc.
Fresenius Medical Care Announces Signing of Definitive Agreement to Divest Facilities in Connection with Renal Care Group Acquisition.
Fresenius Medical Care Purchases Avega's Alliance Decision Support(TM).
Fresenius Medical Care Announces New Sourcing and Supply Agreement with Amgen.
Fresenius Medical Care to Acquire Phosphate Binder Business from Nabi Biopharmaceuticals.
Fresenius Medical Care Reports Excellent Revenue and EBIT Growth in the Third Quarter and Nine Months 2006; Outlook for 2006 Upgraded.

Terms of use | Copyright © 2009 Farlex, Inc. | Feedback | For webmasters | Submit articles